iRhythm Holdings, Inc.
IRTC Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 26, 2026
$121.93
KIRA · Stoqly’s AI analyst, in plain words
- iRhythm Holdings, Inc. had $747M of revenue in fiscal 2025, up 26.2% on the year before. Over five years, revenue changed +23.0% a year on average.
- Its operating margin was −7.7%, up 11.8 pts: of every 100 in sales, about −8 is left after running the business.
- iRhythm Holdings, Inc. lost $44.6M in fiscal 2025.
- Free cash flow was $34.5M in fiscal 2025, 4.6% of revenue.
- iRhythm Holdings, Inc. returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count rose 2.6%.
Market cap
$4.0B
P/E
—
Revenue
$747M
Net income
−$44.6M
Free cash flow
$34.5M
Operating margin
−7.7%
iRhythm Holdings, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+26.2%
Yes. Sales grew 26.2% last year.
Does it make a profit?
−6.0%
No. It lost money last year.
Does profit turn into cash?
4.6%
Partly. 4.6% of sales ends up as free cash.
How healthy are the accounts?
5 / 8
Mixed. It passes 5 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What iRhythm Holdings, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 19, 2026
- Legal name
- iRhythm Holdings, Inc.
- CIK
- 0001388658
iRhythm Holdings, Inc. · IRTC
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $323M | $411M | $493M | $592M | $747M |
| Revenue growth | 21.7% | 27.3% | 19.9% | 20.1% | 26.2% |
| Gross margin | 66.2% | 68.5% | 67.3% | 68.9% | 70.6% |
| Operating margin | −31.0% | −27.7% | −25.4% | −19.5% | −7.7% |
| Net income | −$101M | −$116M | −$123M | −$113M | −$44.6M |
| Net margin | −31.4% | −28.3% | −25.0% | −19.1% | −6.0% |
| Diluted EPS | −$3.46 | −$3.88 | −$4.04 | −$3.63 | −$1.39 |
| Cash | |||||
| Cash from operations | −$37.8M | −$23.0M | −$50.1M | $3.4M | $80.9M |
| Capital expenditure | $28.1M | $29.8M | $40.4M | $33.9M | $46.3M |
| Free cash flow | −$65.8M | −$52.8M | −$90.5M | −$30.6M | $34.5M |
| FCF margin | −20.4% | −12.9% | −18.4% | −5.2% | 4.6% |
| Share buybacks | — | $0.0M | $0.0M | $25.0M | $0.0M |
| Share count change | 5.7% | 2.0% | 2.0% | 2.2% | 2.6% |
| Debt and strength | |||||
| Cash and short-term investments | $239M | $213M | $134M | $536M | $584M |
| Debt incl. finance leases | $21.4M | $34.9M | $35.0M | — | — |
| Shareholders' equity | $280M | $240M | $210M | $90.9M | $153M |
| Current ratio | 3.5x | 3.2x | 2.1x | 5.8x | 4.6x |
| Interest coverage | −85.5x | −27.5x | −34.3x | −9.0x | −4.4x |
| Returns and quality | |||||
| Return on capital | −127.9% | −145.9% | −88.9% | — | — |
| Return on equity | −32.6% | −44.7% | −54.9% | −75.3% | −36.6% |
| Return on tangible equity | −36.4% | −48.6% | −59.0% | −125.8% | −29.3% |
| Piotroski F-score | 3 | 3 | 2 | 5 | 5 |
| Altman Z'' | 0.4 | −1.4 | −3.9 | 0.4 | 0.8 |
Insiders bought, 12 months
$0.1M
1 insider
Insiders sold, 12 months
$29.6M
12 insiders
Of sales under plans
15%
$4.5M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
iRhythm Holdings, Inc. · IRTC
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $121.93 a share, the company is worth $4.0B.
Source: SEC EDGAR XBRL filings (CIK 0001388658). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.